Mariola Fotin-Mleczek
Signal active
Chief Technology Officer
Contact Information
Social
Primary Organization
CureVac
Founded
2000
Employees
251-500
Industry
Biotechnology, Biopharma, Therapeutics
Bio
Trained in biology, at the University of Stuttgart. Her scientific expertise includes immunology, cell biology, signal transduction, apoptosis and cellular uptake.
She joined CureVac in Mai 2006 when she was responsible for the development and preclinical testing of RNActive® cancer vaccines.
She is inventor of RNActive® related key patents and she authored several publications on mRNA technology.
Location
Tübingen, Baden-Wurttemberg, Germany, Europe
Jobs history
1
CureVac
Chief Technology Officer
2018 - Current
Board and Advisor Roles
0
N/A
Educations
1
University of Stuttgart
Technical biology
Profile Resume
Mariola Fotin-Mleczek is the Chief Technology Officer at CureVac, based in Europe. With a background in Biotechnology, Mariola Fotin-Mleczek has a rich history of leadership and innovation.Mariola Fotin-Mleczek studied Diploma Technical biology at University of Stuttgart. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity